VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HRHealthcare Realty Trust Incorporated
$19.20$6.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHRFinancials

Healthcare Realty Trust Incorporated (HR) Income Statement

30Y historyFree accessUpdated daily

Revenue has contracted about 9.4% from $316.3M in 2024Q2 to $286.6M in 2026Q3 while NOI margin swung from roughly -47% to about 64%, a recovery that warrants scrutiny of its underlying classification.

Income StatementBalance SheetCash FlowRatios

HR Income Statement

Annual statement

HR Income Statement

Healthcare Realty Trust Incorporated (HR) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue1.13B1.18B1.27B1.34B932.64M534.82M735.07M693.63M695.3M613.11M460.48M403.41M371.05M317.92M299.64M274.44M199.88M129.49M80.42M17.63M0158.76M176.95M149.44M136.65M145.05M151.68M153.4M80M51.8M31.3M
Revenue Growth %-5.83%-6.92%-5.62%44.08%74.38%-27.24%5.97%-0.24%13.4%33.15%14.15%8.72%16.71%6.1%9.18%37.3%54.36%61.02%356.25%--100%-10.28%18.41%9.36%-5.79%-4.37%-1.12%91.75%54.44%65.5%10.6%
Property Operating Expenses668.51M1.58B1.82B1.96B1.25B617.7M925.23M890.47M778.75M681.24M497.03M431.24M393.92M336.05M328.14M252.51M181.48M130.27M92.8M23.85M00000000000
Net Operating Income (NOI)465.28M-396.46M-555.43M-618.09M-317.56M-82.88M-190.16M-196.84M-83.45M-68.13M-36.55M-27.84M-22.87M-18.13M-28.5M21.93M18.4M-783K-12.38M-6.22M0158.76M176.95M149.44M136.65M145.05M151.68M153.4M80M51.8M31.3M
NOI Margin %41.04%-33.58%-43.79%-46%-34.05%-15.5%-25.87%-28.38%-12%-11.11%-7.94%-6.9%-6.16%-5.7%-9.51%7.99%9.21%-0.6%-15.4%-35.31%-100%100%100%100%100%100%100%100%100%100%
Operating Expenses205.45M-491.4M-591.84M-667.89M-396.29M-168.56M-259.89M-246.67M-243.43M-206.58M-142.9M-123.23M-103.07M-93.92M-51.25M12.1M9.34M8.24M3.67M298K241.77K158.76M176.95M149.44M136.65M145.05M151.68M153.4M80M51.8M31.3M
G&A Expenses44.14M0000000000000000000016.09M13.69M11.82M22.66M10.11M8.74M7.3M11.1M3.8M2.2M
EBITDA807.48M658.9M758.73M825.7M556.5M292.19M264.55M230.71M327.18M284.8M237.38M249.53M220.63M195.29M139.17M117.37M86.41M44.57M21.34M3.27M-241.77K0000000000
EBITDA Margin %71.22%55.81%59.82%61.45%59.67%54.63%35.99%33.26%47.06%46.45%51.55%61.86%59.46%61.43%46.45%42.77%43.23%34.42%26.54%18.55%-0%0%0%0%0%0%0%0%0%0%
Depreciation & Amortization547.65M563.97M722.32M775.89M477.78M206.51M194.82M180.87M167.2M146.35M131.04M154.13M140.43M119.5M116.42M107.54M77.34M53.59M37.4M9.79M063.53M57.42M46.7M46.94M45.13M42.94M41.2M17.1M12.1M9M
D&A / Revenue %48.3%47.77%56.95%57.74%51.23%38.61%26.5%26.08%24.05%23.87%28.46%38.21%37.85%37.59%38.85%39.19%38.69%41.39%46.5%55.54%-40.02%32.45%31.25%34.35%31.11%28.31%26.86%21.38%23.36%28.75%
Operating Income259.83M94.94M36.41M49.81M78.73M85.68M69.73M49.84M159.98M138.45M106.34M95.4M80.2M75.79M22.75M9.83M9.07M-9.03M-16.06M-6.52M-241.77K0000000000
Operating Margin %22.92%8.04%2.87%3.71%8.44%16.02%9.49%7.18%23.01%22.58%23.09%23.65%21.62%23.84%7.59%3.58%4.54%-6.97%-19.97%-37%-0%0%0%0%0%0%0%0%0%0%
Interest Expense4M205.48M255.38M268.66M141.93M52.53M00101.56M84.27M56.77M58.11M57.49M52.26M45.33M39.61M35.34M29.35M21.34M5.02M047.98M43.25M34.64M34.27M38.11M42.99M38.6M13.1M8M7.3M
Interest Coverage--0.21x-1.60x-0.05x1.29x2.27x--3.14x1.78x1.91x1.58x1.80x1.45x0.46x1.14x0.73x0.16x-0.33x-0.53x--1.32x-1.33x-1.35x-1.37x-1.18x-1.00x-1.07x-1.31x-1.51x-1.23x
Non-Operating Income93.23M138.94M444.94M63.23M-103.9M-33.51M16.22M19.08M-159.21M-11.39M-1.81M3.73M-23.28M-42K1.8M-35.38M-16.85M-13.6M-8.99M-3.87M063.53M57.42M46.7M46.94M45.13M42.94M41.2M17.1M12.1M9M
Pretax Income-45.19M-249.49M-663.9M-282.08M40.69M66.66M53.51M30.76M217.63M65.58M51.38M33.56M45.99M23.58M-24.37M5.59M-9.41M-24.77M-28.41M-7.67M-241.77K0000000000
Pretax Margin %-3.99%-21.13%-52.35%-20.99%4.36%12.46%7.28%4.43%31.3%10.7%11.16%8.32%12.4%7.42%-8.13%2.04%-4.71%-19.13%-35.33%-43.54%-0%0%0%0%0%0%0%0%0%0%
Income Tax00000000000000000000048.97M43.9M34.6M34.2M38.11M42.99M38.6M13.1M8M7.3M
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%----------
Net Income-44.93M-246.07M-654.49M-278.26M40.9M66.66M52.62M30.15M213.46M63.92M49.95M32.93M45.37M24.26M-24.42M5.54M-7.9M-25.08M-28.45M-7.67M-241.77K52.67M55.53M60.4M62.38M79.89M79.8M86M40.5M31.2M19.7M
Net Margin %-3.96%-20.84%-51.6%-20.71%4.39%12.46%7.16%4.35%30.7%10.42%10.85%8.16%12.23%7.63%-8.15%2.02%-3.95%-19.37%-35.38%-43.49%-33.17%31.38%40.42%45.65%55.08%52.61%56.06%50.63%60.23%62.94%
Net Income Growth %87.77%62.4%-135.21%-780.39%-38.65%26.68%74.5%-85.87%233.97%27.96%51.68%-27.42%87.01%199.33%-540.79%170.11%68.49%11.85%-271.09%-3070.77%-100.46%-5.16%-8.06%-3.18%-21.91%0.11%-7.21%112.35%29.81%58.38%7.65%
Funds From Operations (FFO)502.72M317.89M67.83M497.63M518.67M273.17M247.43M211.03M380.66M210.27M180.99M187.06M185.8M143.76M91.99M113.08M69.44M28.52M8.95M2.12M65.29M116.2M112.95M107.1M109.32M125.02M122.74M127.2M57.6M43.3M28.7M
FFO Margin %44.34%26.93%5.35%37.03%55.61%51.08%33.66%30.42%54.75%34.3%39.31%46.37%50.08%45.22%30.7%41.21%34.74%22.02%11.13%12.05%-73.19%63.83%71.67%80%86.19%80.92%82.92%72%83.59%91.69%
FFO Growth %1705.52%368.65%-86.37%-4.06%89.88%10.4%17.25%-44.56%81.04%16.17%-3.25%0.68%29.25%56.27%-18.65%62.86%143.48%218.64%321.37%-96.75%-43.81%2.87%5.46%-2.03%-12.56%1.86%-3.51%120.83%33.03%50.87%8.71%
FFO per Share1.480.910.191.312.041.911.121.011.811.131.291.461.531.250.831.010.840.510.420.4380502.132.452.522.562.633.083.053.202.352.332.17
FFO Payout Ratio %49.84%121.71%674.98%94.9%271.34%64.23%65.7%73.62%39.47%67.69%72.8%64.29%62.63%77.61%104.74%78.94%109.2%320.45%908.39%4761.63%193.31%107.87%102.43%97.37%96.87%80.52%78.41%72.56%74.48%82.68%87.8%
EPS (Diluted)-0.13-0.71-1.81-0.740.150.450.240.141.020.350.330.260.370.21-0.220.04-0.10-0.44-1.32-1.54-298.061.111.241.441.371.671.821.991.631.681.49
EPS Growth %86.58%60.77%-144.59%-593.33%-66.67%87.5%71.43%-86.27%191.43%6.06%26.92%-29.73%76.19%195.45%-650%140%77.27%66.67%14.29%99.48%-26952.25%-10.48%-13.89%5.11%-17.96%-8.24%-8.54%22.09%-2.98%12.75%5.67%
EPS (Basic)--0.71-1.81-0.740.150.450.240.151.040.350.340.260.380.21-0.220.04-0.10-0.44-1.32-1.54-298.061.131.271.471.401.701.852.021.661.711.49
Diluted Shares Outstanding340.62M349.8M365.55M378.93M253.87M142.71M221.67M209.6M210.06M185.28M140.26M128M121.17M114.97M111.36M112.2M82.98M56.41M21.42M4.98M81147.45M44.78M41.84M41.49M40.61M40.3M39.81M24.52M18.57M13.25M

Key Metrics

Growth RegimeContracting
ProfitabilityWeak
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Persistent Revenue Contraction Pressure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Erosion Despite Stabilizing Net Operating Income

Based on reported quarterly figures, HR's revenue declined from $316.3M in 2024Q2 to $286.6M in 2026Q3, a cumulative contraction of roughly 9.4% that warrants closer examination of the drivers behind it.

The revenue trajectory suggests a sustained downward slope rather than a transient dip, with year-over-year declines ranging from 3.7% to 8.5% across the period. NOI, however, appears to have stabilized near $178-184M in the most recent three quarters after deeply negative readings in 2024 and 2025, which may indicate that property-level profitability has reset to a more consistent base. Investors should monitor whether occupancy, rent spreads, or disposition activity is driving the top-line decline, as the data alone does not isolate the cause.

NOI Margin Recovery Requires Scrutiny

As reported in the quarterly income statements, HR's NOI margin moved from negative territory in 2025 to roughly 64% in 2026, a shift that appears large enough to warrant verification of its underlying classification.

The jump from roughly -28% to 64% over a few quarters is unusually sharp for a MOB portfolio and may reflect changes in how operating expenses or depreciation were aggregated in the source data rather than a purely operational improvement. Once a stable 64% margin is established, it would be consistent with healthcare REIT norms, but the prior negative readings suggest the margin series may not be fully comparable across periods. Analysts should reconcile these figures against SEC-filed property operating expense schedules before drawing conclusions about cost discipline.

FFO Volatility and Per-Share Dilution Concerns

According to the reported figures, HR's FFO per share swung between $-0.03 and $0.41 over ten quarters, with the most recent reading of $0.33 still below the 2025Q4 peak of $0.41.

FFO has been erratic, with a negative print in 2025Q2 and a sharp rebound thereafter, which suggests either lumpy non-recurring items or share count changes affecting the per-share figure. The most recent AFFO reading of $26.3M in 2026Q2 is substantially lower than the $79.6M in 2026Q1, implying that recurring capital needs may be absorbing a meaningful portion of cash earnings. Dividend coverage appears thinner than the headline FFO suggests, and investors should monitor whether AFFO payout ratios remain sustainable.

Earnings Distortion From Non-Cash Charges

Based on reported net income of -$15.8M in 2026Q3 against FFO of $112.3M, the roughly $128M gap points to a large non-cash charge layer that GAAP earnings alone would obscure.

The persistent divergence between GAAP net income and FFO across the period implies that real estate depreciation and amortization, potentially including merger-related intangible amortization from the HTA integration, dominate reported earnings. This is consistent with REIT accounting conventions, but the magnitude of the gap in several quarters suggests impairment or amortization effects that may not recur. Maintenance CAPEX and tenant improvement spending, which are not captured in FFO, deserve separate scrutiny in AFFO reconciliation.

Earnings Quality Challenges to the Recovery Narrative

The recent NOI recovery and FFO rebound in HR's reported figures may overstate underlying earnings durability, since AFFO fell to $26.3M in 2026Q2 and EPS remains negative in most recent quarters.

If the 2026 NOI margin reflects reclassification rather than operating improvement, the headline recovery would be a presentation artifact rather than a genuine turn. Straight-line rent adjustments and capitalized leasing costs could also flatter FFO relative to recurring cash generation. Investors should treat the stabilization thesis as unproven until revenue growth turns positive and AFFO coverage of the dividend is demonstrated consistently across quarters.

HR — Frequently Asked Questions

Quick answers to the most common questions about buying HR stock.

What was Healthcare Realty Trust Incorporated's (HR) revenue in 2025?

For fiscal year 2025, Healthcare Realty Trust Incorporated (HR) reported total revenue of $1.18B. This represents a 3671.7% increase compared to $31.3M in 1996.

Is Healthcare Realty Trust Incorporated (HR) profitable?

Healthcare Realty Trust Incorporated (HR) reported a net loss of $246.1M for the fiscal year ending 2025.

What is Healthcare Realty Trust Incorporated's operating profit margin?

Healthcare Realty Trust Incorporated (HR) reported an operating income of $94.9M, resulting in an operating profit margin of 8.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Healthcare Realty Trust Incorporated's gross profit and gross margin?

Healthcare Realty Trust Incorporated (HR) generated $-396.5M in gross profit for the year, representing a gross profit margin of -33.6%. This demonstrates the company's core pricing power and production efficiency.